Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

The tumor suppressor FOXO3a mediates the response to EGFR inhibition in glioblastoma cells.

Ramis G, Villalonga-Planells R, Serra-Sitjar M, Brell M, Fernández de Mattos S, Villalonga P.

Cell Oncol (Dordr). 2019 Aug;42(4):521-536. doi: 10.1007/s13402-019-00443-1. Epub 2019 Apr 13.

PMID:
30980364
2.

N-(2-methyl-indol-1H-5-yl)-1-naphthalenesulfonamide: A novel reversible antimitotic agent inhibiting cancer cell motility.

Aceves-Luquero C, Galiana-Roselló C, Ramis G, Villalonga-Planells R, García-España E, Fernández de Mattos S, Peláez R, Llinares JM, González-Rosende ME, Villalonga P.

Biochem Pharmacol. 2016 Sep 1;115:28-42. doi: 10.1016/j.bcp.2016.06.016. Epub 2016 Jun 25.

PMID:
27349984
3.

Efficacy of the GemOx-R regimen leads to the identification of Oxaliplatin as a highly effective drug against Mantle Cell Lymphoma.

Obrador-Hevia A, Serra-Sitjar M, Rodríguez J, Belayachi L, Bento L, García-Recio M, Sánchez JM, Villalonga P, Gutiérrez A, Fernández de Mattos S.

Br J Haematol. 2016 Sep;174(6):899-910. doi: 10.1111/bjh.14141. Epub 2016 May 25.

PMID:
27220900
4.

Pro-Oxidant Activity of Amine-Pyridine-Based Iron Complexes Efficiently Kills Cancer and Cancer Stem-Like Cells.

González-Bártulos M, Aceves-Luquero C, Qualai J, Cussó O, Martínez MA, Fernández de Mattos S, Menéndez JA, Villalonga P, Costas M, Ribas X, Massaguer A.

PLoS One. 2015 Sep 14;10(9):e0137800. doi: 10.1371/journal.pone.0137800. eCollection 2015.

5.

Cell uptake and localization studies of squaramide based fluorescent probes.

Sampedro A, Villalonga-Planells R, Vega M, Ramis G, Fernández de Mattos S, Villalonga P, Costa A, Rotger C.

Bioconjug Chem. 2014 Aug 20;25(8):1537-46. doi: 10.1021/bc500258b. Epub 2014 Jul 24.

PMID:
25036647
6.

Retama monosperma n-hexane extract induces cell cycle arrest and extrinsic pathway-dependent apoptosis in Jurkat cells.

Belayachi L, Aceves-Luquero C, Merghoub N, Bakri Y, Fernández de Mattos S, Amzazi S, Villalonga P.

BMC Complement Altern Med. 2014 Jan 24;14:38. doi: 10.1186/1472-6882-14-38.

7.

Cyclosquaramides as kinase inhibitors with anticancer activity.

Villalonga P, Fernández de Mattos S, Ramis G, Obrador-Hevia A, Sampedro A, Rotger C, Costa A.

ChemMedChem. 2012 Aug;7(8):1472-80. doi: 10.1002/cmdc.201200157. Epub 2012 Jul 9.

PMID:
22777958
8.

EGFR inhibition in glioma cells modulates Rho signaling to inhibit cell motility and invasion and cooperates with temozolomide to reduce cell growth.

Ramis G, Thomàs-Moyà E, Fernández de Mattos S, Rodríguez J, Villalonga P.

PLoS One. 2012;7(6):e38770. doi: 10.1371/journal.pone.0038770. Epub 2012 Jun 6. Retraction in: PLoS One. 2019 Sep 3;14(9):e0222210.

9.

The tumour suppressor FOXO3 is a key regulator of mantle cell lymphoma proliferation and survival.

Obrador-Hevia A, Serra-Sitjar M, Rodríguez J, Villalonga P, Fernández de Mattos S.

Br J Haematol. 2012 Feb;156(3):334-45. doi: 10.1111/j.1365-2141.2011.08951.x. Epub 2011 Nov 23.

PMID:
22107151
10.

Therapeutic concepts in mantle cell lymphoma.

Rodriguez J, Gutierrez A, Obrador-Hevia A, Fernandez de Mattos S, Cabanillas F.

Eur J Haematol. 2010 Nov;85(5):371-86. doi: 10.1111/j.1600-0609.2010.01515.x. Review.

PMID:
20727006
11.

Hydrogen peroxide regulates the mitochondrial content of uncoupling protein 5 in colon cancer cells.

Santandreu FM, Valle A, Fernández de Mattos S, Roca P, Oliver J.

Cell Physiol Biochem. 2009;24(5-6):379-90. doi: 10.1159/000257430. Epub 2009 Nov 4.

12.

RhoE inhibits 4E-BP1 phosphorylation and eIF4E function impairing cap-dependent translation.

Villalonga P, Fernández de Mattos S, Ridley AJ.

J Biol Chem. 2009 Dec 18;284(51):35287-96. doi: 10.1074/jbc.M109.050120.

13.

Molecular biology of mantle cell lymphoma: from profiling studies to new therapeutic strategies.

Obrador-Hevia A, Fernández de Mattos S, Villalonga P, Rodríguez J.

Blood Rev. 2009 Sep;23(5):205-16. doi: 10.1016/j.blre.2009.03.001. Epub 2009 Apr 10. Review.

PMID:
19362399
14.

FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells.

Fernández de Mattos S, Villalonga P, Clardy J, Lam EW.

Mol Cancer Ther. 2008 Oct;7(10):3237-46. doi: 10.1158/1535-7163.MCT-08-0398.

15.

The forkhead transcription factor FOXO3a increases phosphoinositide-3 kinase/Akt activity in drug-resistant leukemic cells through induction of PIK3CA expression.

Hui RC, Gomes AR, Constantinidou D, Costa JR, Karadedou CT, Fernandez de Mattos S, Wymann MP, Brosens JJ, Schulze A, Lam EW.

Mol Cell Biol. 2008 Oct;28(19):5886-98. doi: 10.1128/MCB.01265-07. Epub 2008 Jul 21.

16.

Increase in Fru-2,6-P(2) levels results in altered cell division in Schizosaccharomyces pombe.

Fernández de Mattos S, Alemany V, Aligué R, Tauler A.

Biochim Biophys Acta. 2008 Jan;1783(1):144-52. Epub 2007 Jul 24.

17.

Progestins regulate the expression and activity of the forkhead transcription factor FOXO1 in differentiating human endometrium.

Labied S, Kajihara T, Madureira PA, Fusi L, Jones MC, Higham JM, Varshochi R, Francis JM, Zoumpoulidou G, Essafi A, Fernandez de Mattos S, Lam EW, Brosens JJ.

Mol Endocrinol. 2006 Jan;20(1):35-44. Epub 2005 Aug 25.

PMID:
16123151
18.

Quiescence and functional reprogramming of Epstein-Barr virus (EBV)-specific CD8+ T cells during persistent infection.

Dunne PJ, Belaramani L, Fletcher JM, Fernandez de Mattos S, Lawrenz M, Soares MV, Rustin MH, Lam EW, Salmon M, Akbar AN.

Blood. 2005 Jul 15;106(2):558-65. Epub 2005 Mar 29.

PMID:
15797994
19.

Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells.

Essafi A, Fernández de Mattos S, Hassen YA, Soeiro I, Mufti GJ, Thomas NS, Medema RH, Lam EW.

Oncogene. 2005 Mar 31;24(14):2317-29.

PMID:
15688014
20.

FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanism.

Fernández de Mattos S, Essafi A, Soeiro I, Pietersen AM, Birkenkamp KU, Edwards CS, Martino A, Nelson BH, Francis JM, Jones MC, Brosens JJ, Coffer PJ, Lam EW.

Mol Cell Biol. 2004 Nov;24(22):10058-71.

21.

Convergence of interferon-gamma and progesterone signaling pathways in human endometrium: role of PIASy (protein inhibitor of activated signal transducer and activator of transcription-y).

Zoumpoulidou G, Jones MC, Fernandez de Mattos S, Francis JM, Fusi L, Lee YS, Christian M, Varshochi R, Lam EW, Brosens JJ.

Mol Endocrinol. 2004 Aug;18(8):1988-99. Epub 2004 May 20.

PMID:
15155784
22.

FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines.

Sunters A, Fernández de Mattos S, Stahl M, Brosens JJ, Zoumpoulidou G, Saunders CA, Coffer PJ, Medema RH, Coombes RC, Lam EW.

J Biol Chem. 2003 Dec 12;278(50):49795-805. Epub 2003 Oct 3.

23.

Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D.

Schmidt M, Fernandez de Mattos S, van der Horst A, Klompmaker R, Kops GJ, Lam EW, Burgering BM, Medema RH.

Mol Cell Biol. 2002 Nov;22(22):7842-52.

25.

Jab1 co-activation of c-Jun is abrogated by the serine 10-phosphorylated form of p27Kip1.

Chopra S, Fernandez De Mattos S, Lam EW, Mann DJ.

J Biol Chem. 2002 Sep 6;277(36):32413-6. Epub 2002 Jul 15.

26.

An intronic AP-1 sequence mediates the transcriptional activation of the F-type 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase by serum.

Joaquin M, Salvadó C, Fernández de Mattos S, Tauler A.

Biochim Biophys Acta. 2002 Mar 19;1574(2):131-6.

PMID:
11955621
27.

H2O2 induces a transient multi-phase cell cycle arrest in mouse fibroblasts through modulating cyclin D and p21Cip1 expression.

Barnouin K, Dubuisson ML, Child ES, Fernandez de Mattos S, Glassford J, Medema RH, Mann DJ, Lam EW.

J Biol Chem. 2002 Apr 19;277(16):13761-70. Epub 2002 Feb 4.

28.

Supplemental Content

Loading ...
Support Center